Compare
Meihua International Medical Technologies Co., Ltd. vs LENSAR, Inc. vs CVRx, Inc. vs AVITA Medical, Inc.
| Latest fiscal year | Meihua International Medical Technologies Co., Ltd. MHUAF | LENSAR, Inc. LNSR | CVRx, Inc. CVRX | AVITA Medical, Inc. RCEL |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $61.79M | $58.44M | $56.65M | $71.61M |
| Revenue growth (YoY) | -36.2% | +9.2% | +10.4% | +11.5% |
| Gross margin | 31.0% | 46.4% (computed) | 85.3% | 82.1% |
| Operating margin | 13.4% | -42.1% | -90.5% | -59.4% |
| Net margin | 11.0% | -58.7% | -94.1% | -67.8% |
| Net income | $6.78M | -$34.28M | -$53.31M | -$48.59M |
| EPS (Diluted) | $18.04 | -$2.87 | -$2.04 | -$1.74 |
| Operating cash flow | $569.9K | -$14.83M | -$40.17M | -$31.20M |
| Free cash flow | $554.3K | -$14.91M | -$40.75M | -$32.20M |
| Cash & equivalents | n/a | $12.97M | $75.71M | $10.24M |
| Total assets | $207.18M | $71.43M | $104.79M | $56.39M |
| Total liabilities | n/a | $83.67M | $65.47M | $73.04M |
| Shareholders' equity | $188.93M | -$26.02M | $39.32M | -$16.65M |
| Return on year-end equity | 3.6% | n/a | -135.6% | n/a |
| Shares outstanding | n/a | 11.99M | 26.31M | 30.57M |
Revenue, most recent five fiscal years
| Fiscal year | Meihua International Medical Technologies Co., Ltd. | LENSAR, Inc. | CVRx, Inc. | AVITA Medical, Inc. |
|---|---|---|---|---|
| Latest | $61.79M Ended 2025-12-31 | $58.44M Ended 2025-12-31 | $56.65M Ended 2025-12-31 | $71.61M Ended 2025-12-31 |
| 1 year earlier | $96.91M Ended 2024-12-31 | $53.49M Ended 2024-12-31 | $51.29M Ended 2024-12-31 | $64.25M Ended 2024-12-31 |
| 2 years earlier | $97.10M Ended 2023-12-31 | $42.16M Ended 2023-12-31 | $39.30M Ended 2023-12-31 | $50.14M Ended 2023-12-31 |
| 3 years earlier | $103.35M Ended 2022-12-31 | $35.36M Ended 2022-12-31 | $22.47M Ended 2022-12-31 | $34.42M Ended 2022-12-31 |
| 4 years earlier | $104.04M Ended 2021-12-31 | $34.46M Ended 2021-12-31 | $13.04M Ended 2021-12-31 | n/a |